A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of ...

India may be encountering a silent epidemic of diabetes. Regular monitoring of blood sugar may no longer be just medical ...

A man with long-standing type 1 diabetes underwent transplant with UP421 gene-edited islet cells designed to avoid rejection.

Over the course of several months, her HbA1c was persistently elevated at 12–14% with mildly elevated blood sugar readings.

HbA1c was assessed at baseline and at 3, 12 and 24 months. Of the study participants, 193 were receiving metformin, 99 were receiving insulin, five were receiving a GLP-1 receptor agonist and one ...

With a mean baseline HbA1c of 7.0–7.9%, therapies with oral antidiabetic medication achieved an HbA1c reduction of 0.1%, while in our study the baseline HbA1c in the intervention group was 7.1 ...

The study authors reported that smaller reductions in the HbA1c were seen in RW patients initiated on a GLP-1RA or DPP4 compared to reductions reported from RCTs. For RW patients initiated on a ...

Among infants born to white mothers, increases in HbA1c levels from 4.8% to 6% increased the risk for hypoglycemia from 25% to 48% in late preterm, and from 12% to 22% in term deliveries.

The Global HbA1c Testing Market will witness a growth rate of 9-12% by 2028. The market is poised for growth due to the increasing prevalence of diabetes, growing awareness about routine HbA1c testing ...

Six months after treatment initiation, on average patients lowered their HbA1c by 0.77% (from 7.6% to 6.8%) and reduced their body weight by 4.7 kg (from 94.1 kg to 89.7 kg).